Article
Integrative In Silico Transcriptomic and Pharmacogenomic Analysis of CD276 as a Candidate Prognostic Biomarker and Therapeutic Target in Bladder Cancer
2026-02-02
Abstract excerpt
<title>Abstract</title> <p>Despite recent advances in bladder cancer treatment, therapeutic resistance remains a critical challenge, necessitating the identification of novel molecular targets. This study used an integrative in silico approach to evaluate the prognostic value and molecular landscape of the immune regulatory molecule CD276 (B7-H3). Analyses of TCGA and GTEx datasets showed that CD276 is significan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 805cca98-e8e0-5388-85b5-f3d146eacd6b
- DOI
- 10.21203/rs.3.rs-8563890/v1
